Antithrombin deficiency, whether inherited or acquired, poses a significant risk factor for venous thromboembolism (VTE) by impairing the natural regulation of coagulation. As a critical plasma ...
Thrombate III is the only antithrombin concentrate approved in both adult and pediatric patients for hereditary antithrombin deficiency. The Food and Drug Administration (FDA) has expanded the ...